In the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile ...

A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office, reviving a spat between Recor Medical ...

Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Medical Devices Market Size Medical Devices Market Share Leading companies in the medical devices market include Johnson & Johnson S ...

Medtronic (MDT) closed at $88.86 in the latest trading session, marking a +0.42% move from the prior day. This change lagged the S&P 500's 0.67% gain on the day. Meanwhile, the Dow experienced a rise ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Dr. Keshav Kale explained, “The patient’s combination of bradycardia, Degenerative CHB, and severe thrombocytopenia made ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...